U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...